These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1671042)

  • 21. p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma.
    Nanni P; Pupa SM; Nicoletti G; De Giovanni C; Landuzzi L; Rossi I; Astolfi A; Ricci C; De Vecchi R; Invernizzi AM; Di Carlo E; Musiani P; Forni G; Menard S; Lollini PL
    Int J Cancer; 2000 Jul; 87(2):186-94. PubMed ID: 10861472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
    Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
    J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy.
    Meden H; Marx D; Fattahi A; Rath W; Kron M; Wuttke W; Schauer A; Kuhn W
    J Cancer Res Clin Oncol; 1994; 120(6):378-81. PubMed ID: 7908021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.
    Shi D; He G; Cao S; Pan W; Zhang HZ; Yu D; Hung MC
    Mol Carcinog; 1992; 5(3):213-8. PubMed ID: 1350198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage.
    Pupa SM; Ménard S; Morelli D; Pozzi B; De Palo G; Colnaghi MI
    Oncogene; 1993 Nov; 8(11):2917-23. PubMed ID: 8105438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma.
    Bermont L; Algros MP; Baron MH; Adessi GL
    Breast Cancer Res Treat; 2000 Sep; 63(2):163-9. PubMed ID: 11097092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.
    Sarup JC; Johnson RM; King KL; Fendly BM; Lipari MT; Napier MA; Ullrich A; Shepard HM
    Growth Regul; 1991 Jun; 1(2):72-82. PubMed ID: 1688187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.
    Natali PG; Nicotra MR; Bigotti A; Venturo I; Slamon DJ; Fendly BM; Ullrich A
    Int J Cancer; 1990 Mar; 45(3):457-61. PubMed ID: 1968437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular protocol for HER2/neu analysis in breast carcinoma].
    Artufel MV; Valero AC; Lladó RR; Sagalés NE; Llorca MC; Carazo AM; Cardó CC; Torrus XP
    Clin Transl Oncol; 2005 Dec; 7(11):504-11. PubMed ID: 16373062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment.
    Wu JT
    Clin Chim Acta; 2002 Aug; 322(1-2):11-9. PubMed ID: 12104076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p66Shc isoform down-regulated and not required for HER-2/neu signaling pathway in human breast cancer cell lines with HER-2/neu overexpression.
    Xie Y; Hung MC
    Biochem Biophys Res Commun; 1996 Apr; 221(1):140-5. PubMed ID: 8660324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
    Bargmann CI; Weinberg RA
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.
    Arteaga CL; Winnier AR; Poirier MC; Lopez-Larraza DM; Shawver LK; Hurd SD; Stewart SJ
    Cancer Res; 1994 Jul; 54(14):3758-65. PubMed ID: 7913407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins.
    Miller P; DiOrio C; Moyer M; Schnur RC; Bruskin A; Cullen W; Moyer JD
    Cancer Res; 1994 May; 54(10):2724-30. PubMed ID: 7909494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation.
    Epstein RJ; Druker BJ; Roberts TM; Stiles CD
    J Biol Chem; 1990 Jun; 265(18):10746-51. PubMed ID: 1972380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
    Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
    Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into the down-regulation of overexpressed p185(her2/neu) protein of transformed cells by the antibody chA21.
    Zhou H; Zha Z; Liu Y; Zhang H; Zhu J; Hu S; Shen G; Cheng L; Niu L; Greene MI; Teng M; Liu J
    J Biol Chem; 2011 Sep; 286(36):31676-83. PubMed ID: 21680730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
    Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
    Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.